Skip to main content
. 2021 Aug 11;13(8):e17115. doi: 10.7759/cureus.17115

Table 1. Hormone levels of the patients according to the months of treatment.

LH: luteinizing hormone; FSH: follicle-stimulating hormone; fT: free testosterone; tT: total testosterone; DHEAS: dehydroepiandrosterone sulfate; 17-OH PG: 17-OH progesterone, SHBG: sex hormone-binding globulin.

*p < 0.05.

  Before treatment (a) Third month of treatment (b) Sixth month of treatment (c) p Difference
LH 6.83±7.89 8.01±5.58 6.9±9.85 0.51 -
FSH 3.66±1.83 4.08±1.54 3.74±2.36 0.19 -
fT 1.64±0.5 2.24±0.98 2.23±0.88 0.01* a-b (p=0.01)* a-c (p=0.01)* b-c (p=0.86)
tT 0.39±0.11 0.63±1.22 0.54±0.2 0,01* a-b (p=0.01)* a-c (p=0.01)* b-c (p=0.08)
DHEAS 332.8±110.54 360.21±132.2 366.89±117.57 0.01* a-b (p=0.01)* a-c (p=0.01)* b-c (p=0.06)
17-OH PG 2.31±1.43 2.63±2.97 2.52±1.71 0.44 -
SHBG 51.45±20.62 56.7±38.55 41.31±17.43 0.01* a-b (p=0.16) a-c (p=0.01)* b-c (p=0.01)*